See also this year's filing and all EDGAR filings for this company.
PDF Report 0001733413_2024_TFF_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001733413, TFF Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,590,318 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,999,781 |
| 3 | remainder_Assets | 2,437,217 |
| 4 | LiabilitiesCurrent | 2,428,540 |
| 5 | LiabilitiesNoncurrent | 31,742 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,351,279 |
| 9 | ResearchAndDevelopmentExpense | 11,176,407 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,304,907 |
| 12 | remainder_NetIncome | 81,223 |
| 13 | remainder_ComprehensiveNetIncome | -8,897 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,027,316 |
| 1 | Liabilities | 2,460,282 |
| 2 | Expenses | 18,527,686 |
| 3 | Revenues | 1,304,907 |
| 4 | StockholdersEquity | 9,567,034 |
| 5 | NetIncome | -17,141,556 |
| 6 | ComprehensiveNetIncome | -17,146,004 |
| 7 | BaseVar | 17,205,156 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.512 |
| 9 | EconomicCapitalRatio | 1.89 |
Edgar->Model Mapping
Feature Distribution
Change over Time
